Quarterly report pursuant to Section 13 or 15(d)

Supplemental Information to Condensed Consolidated Statements of Cash Flows (Detail)

v3.10.0.1
Supplemental Information to Condensed Consolidated Statements of Cash Flows (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Mar. 31, 2018
Sep. 30, 2018
Sep. 30, 2017
Schedule Of Cash Flow Supplemental [Line Items]        
Cash paid for interest     $ 62,773 $ 58,334
Cash paid for income taxes, net of refunds received     42,631 81,271
Noncash investing and financing activities:        
Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment [1]     7,050 (5,947)
Theatre properties acquired under capital lease     4,035 30,517
Investment in NCM – receipt of common units (see Note 7)   $ 5,012 5,012 18,363
Dividends accrued on unvested restricted stock unit awards     (416) [2] $ (423) [3]
NCM        
Noncash investing and financing activities:        
Interest expense - NCM (see Note 3) $ (4,983)   $ (14,875)  
[1] Additions to theatre properties and equipment included in accounts payable as of September 30, 2018 and December 31, 2017 were $38,326 and $31,276, respectively.
[2] Below is a summary of dividends paid to stockholders and accrued on unvested restricted stock unit awards during the nine months ended September 30, 2018: Amount per Share Declaration Date Record Date Payable Date of Common Stock Total 2/23/2018 3/8/2018 3/22/2018 $0.32 $37,471 5/25/2018 6/8/2018 6/22/2018 0.32 37,523 8/23/2018 9/4/2018 9/18/2018 0.32 37,530 Total $0.96 $112,524
[3] Below is a summary of dividends paid to stockholders and accrued on unvested restricted stock unit awards during the nine months ended September 30, 2017: Amount per Share Declaration Date Record Date Payable Date of Common Stock Total 2/23/2017 3/8/2017 3/20/2017 $0.29 $33,912 5/25/2017 6/8/2017 6/22/2017 0.29 33,904 8/10/2017 8/31/2017 9/13/2017 0.29 33,911 Total $0.87 $101,727